Anaphylaxis in Public Health.

Area of Science:

• Allergy and Immunology
• Public Health
• Clinical Medicine

Background:

• Anaphylaxis incidence and prevalence are challenging to ascertain due to a lack of consensus definition and varied methodologies.
• Anaphylaxis poses a significant public health concern, with specific risk factors identified in patient populations.

Purpose of the Study:

• To review current literature on anaphylaxis.
• To discuss recommended practices for anaphylaxis management in public health.
• To highlight new findings regarding anaphylaxis triggers and risk factors.

Main Methods:

• Literature review of recent findings on anaphylaxis.
• Analysis of risk factors, including drug use (ramipril, metoprolol) and dietary factors (gliadin).
• Discussion of diagnostic approaches, such as serum tryptase concentration measurement.

Main Results:

• Anaphylaxis mortality in the US is between 0.63-0.76 per million, with 58% attributed to drug-induced anaphylaxis.
• Ramipril and metoprolol use are identified risk factors, particularly in cardiovascular disease patients.
• Elevated gliadin levels from excess gluten intake are associated with increased anaphylaxis incidence.

Conclusions:

• Accurate anaphylaxis diagnosis requires considering various inflammatory mediators beyond tryptase.
• Understanding risk factors like specific medications and diet is crucial for public health interventions.
• Adherence to professional society guidelines is recommended for managing anaphylaxis.